Joshua Schwochert

Co-founder of Unnatural Products

Appears in 1 story

Last updated Nov 10, 2026

Stories

argenx buys a peptide chemistry company to build oral immunology drugs

Money Moves

Co-founder of the acquired company

Every medicine argenx sells today reaches patients by infusion or injection. On Nov. 9, 2026, the Dutch immunology company agreed to pay $550 million in cash for a Santa Cruz company whose chemistry is built to make pills instead.

Updated 1 hour ago